Industry reports
Editor highlights

Therapy

Summary

Table of Contents

  • Publication date: September 2011
Keywords : biotherapeutics

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' Genova Biotherapeutics, Inc. (formerly Kinder Travel, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances a...

More »

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

Talk to Jordan

+1 917 267 7886

Send Your Request

Therapy Industry : Latest Reports

Fragile X Syndrome - Pipeline Review, H2 2013

Fragile X Syndrome - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Fragile X Syndrome - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Fragile X Syndrome - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

Left Ventricular Dysfunction - Pipeline Review, H2 2013

Left Ventricular Dysfunction - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Left Ventricular Dysfunction - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Left Ventricular Dysfunction - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • December 2013
  • by Global Markets Direct

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

Cellulite - Pipeline Review, H2 2013

December 2013 $ 2 000

Therapy Industry : Latest Downloads

Company Report: Therapeutics for Year 2014

  • Company report
  • March 2014
  • 60 pages

Company Report: Cancer Therapeutics for Year 2013

  • Company report
  • December 2013
  • 2 pages

... Interim analysis, including biomarker data, are being analyzed, and aveo and astellas are in discussions regarding next steps. About aveo aveo oncology (nasdaq: aveo) is a cancer therapeutics company ...

Company Report: Therapeutics for Year 2013

  • Company report
  • December 2013
  • 4 pages
  • by Corporation

... Five prime assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. Five prime therapeutics ...


More Reports:

Related Market Segments :

Therapeutics
Biotherapeutics

Company Reports

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.